CHO-Based Assay Kit

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology, March 2023
Volume 47
Issue 3
Pages: 12

Charles River’s HCP-ELISA kit is designed to increase the efficiency and efficacy of HCP assay development.

Charles River’s HCP-ELISA Kit

Charles River’s HCP-ELISA Kit

Charles River Laboratories’ enzyme-linked immunosorbent assay (ELISA) kit is designed for the detection and quantitation of residual host cell proteins (HCP) in Chinese hamster ovary (CHO)-based biotherapeutics. Building on the company’s HCP-GAPex service, the HCP–ELISA kit is designed to increase the efficiency and efficacy of HCP assay development.

The HCP–ELISA kit has a 96-well assay plate and has a time-to-result of approximately three hours. It leverages avian immunoglobulin Y antibodies as the primary detection technology, which are derived from specific-pathogen-free chicken eggs developed exclusively by AVS Bio.

Charles River Laboratories

Download Issue PDF
Articles in this issue
data web
Harnessing Technology to Ensure Drug Safety
Africa Studio/Stock.adobe.com – Variances and means are compared using F and T tests, respectively.
Justification of Using Weight Variation Instead of Content Uniformity for Release of Relevant OSD Forms
Excipients Impact Stability in mRNA-LNP Formulations
Excipients Impact Stability in mRNA-LNP Formulations
Shopping cart with medical ampoule, syringe and capsules on a blue background, copy space, top view. Concept of purchasing medicines, increasing drug prices. Vertical photo | Image Credit: © yaroslav1986 - Stock.adobe.com
Influencing Change in Drug Delivery
Intestine decorative model with pills on light blue background. Probiotics and prebiotics for microbiome intestine, healthy digestion concept. Top view, flat lay, copy space | Image Credit: © Elena - Stock.adobe.com
Frontrunner in Microbiome Therapeutics
Implementing Process Analytical Technology
Implementing Process Analytical Technology
omar/Stock.Adobe.com
Automated Inspection of Pre-filled Syringes and Biologics During Fill/Finish
Paulista/stock.adobe.com – For high-risk analytical procedures, control-chart monitoring of selected performance data can provide early warning of changes in performance.
Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>
Taking Steps Toward Supply Chain Continuity
Taking Steps Toward Supply Chain Continuity
Medicine, Healthcare And Medicine, Vaccination | Image Credit: © BillionPhotos.com - Stock.adobe.com
Keeping Europe’s Medicines Stocked
WEYO - STOCK.ADOBE.COM - The trends shaping the growth of the biologics outsourcing industry demand attention.
The Logistics of Outsourcing Biologics
Vaccine Development Builds on COVID-19 Breakthroughs
Vaccine Development Builds on COVID-19 Breakthroughs
Landkarte *** Europa | Image Credit: © beugdesign - Stock.adobe.com
EMA Guidance on Paediatric Investigation Plans
Outsourcing Still Vital
Outsourcing Still Vital
Retro classic typewriter from circa 1950s with sheet of paper and aged books on wooden desk front aquamarine wall background. Nostalgic writer's work place concept. Vintage old style filtered photo | Image Credit: © BrAt82 - stock.adobe.com
Feeling the Pinch

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content
3d render, number six glowing in the dark, pink blue neon light | Image Credit: © NeoLeo - stock.adobe.com

The 6-Stage Compounding Framework Every Pharmaceutical Manufacturing Professional Should Know

Christopher Cole
July 17th 2025
Article

A structured, risk-based framework for pharmaceutical compounding that enhances quality, regulatory compliance, and process consistency.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Pharmaceutical research and development in laboratory, with focus on medicine preparation, powder substances, and glass vials for drug formulation and testing | Image Credit: © felix_brönnimann - stock.adobe.com

Dosage Form Compounding in the Workplace Environment

Paul L. Pluta;Alan M. Mancini;Nishant B. Thakar;Varanya Chaiyaperm
July 8th 2025
Article

An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Sterile capsules for injection. Bottles on the bottling line of the pharmaceutical plant. Machine after checking sterile liquids. Interferon, nasoferon. | Image Credit: © neznamov1984 - stock.adobe.com

ten23 health Joins Gerresheimer, SCHOTT, Stevanato Group in ‘Alliance for RTU’

Patrick Lavery
July 1st 2025
Article

The partnership was formed in September 2024 in response to increasing demand for aseptic filling technologies and processes.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

Susan Haigney
June 30th 2025
Article

The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.